Literature DB >> 30033076

Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.

A Berriolo-Riedinger1, S Becker2, O Casasnovas3, T Vander Borght4, V Édeline5.   

Abstract

Fluorodeoxyglucose (FDG) positons emission tomography (PET)-computed tomography (CT) is used in many ways at baseline and during the treatment of patients with Hodgkin lymphoma. Many properties of the technique are used in the different steps of patient's management. Initial staging with PET-CT is more accurate than conventional imaging and PET-CT also became the gold standard imaging at the end of treatment with a negative PET-CT mandatory for reaching a complete remission. Early assessment of response by PET-CT is one of the most powerful prognostic factors for progression-free survival of patients with localized and advanced stages and allows guiding treatment. Conversely, previous studies showed that there is no role of FDG PET-CT for the patient's follow-up.
Copyright © 2018 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hodgkin lymphoma; Imagerie; Interim PET; Lymphome de Hogkin; PET-CT; TEP-scanographie

Mesh：

Substances：

Year:  2018        PMID： 30033076     DOI： 10.1016/j.canrad.2018.06.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN： 1278-3218            Impact factor:   1.018


  6 in total

1.  Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.

Authors:  Michael C Wallace; Kenny Sek; Roslyn J Francis; Shaun Samuelson; John Ferguson; Jonathan Tibballs; Ali Asad; David B Preen; Gerry MacQuillan; George Garas; Leon A Adams; Gary P Jeffrey
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

2.  Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Authors:  Angela Aldin; Lisa Umlauff; Lise J Estcourt; Gary Collins; Karel Gm Moons; Andreas Engert; Carsten Kobe; Bastian von Tresckow; Madhuri Haque; Farid Foroutan; Nina Kreuzberger; Marialena Trivella; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2019-09-16

3.  Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Authors:  Angela Aldin; Lisa Umlauff; Lise J Estcourt; Gary Collins; Karel Gm Moons; Andreas Engert; Carsten Kobe; Bastian von Tresckow; Madhuri Haque; Farid Foroutan; Nina Kreuzberger; Marialena Trivella; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-01-13

4.  Unilateral Ptosis in an Older Adult; a Rare Presentation of Primary Extranodal Hodgkin's Lymphoma.

Authors:  Insija Ilyas Selene; Jemin Aby Jose; Abdur Rehman Jamil; Roma Srivastava; Weichen Wang
Journal:  Case Rep Oncol       Date:  2022-02-14

Review 5.  PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma.

Authors:  Jin Zhao; Xiaojing Guo; Li Ma; Meijing Zheng; Tao Guan; Liping Su
Journal:  Contrast Media Mol Imaging       Date:  2022-08-16       Impact factor: 3.009

6.  Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia.

Authors:  Jemma Arakelyan; Alisa Movsisyan; Lilit Sargsyan; Armine Chopikyan; Diana Andreasyan; Arevik Torosyan; Ruzanna Papyan; Hovhannes Vardevanyan; Samvel Bardakhchyan; Artashes Tadevosyan; Gevorg Tamamyan; Armen Tananyan; Samvel Danielyan; Dickran Kazandjian
Journal:  Ecancermedicalscience       Date:  2021-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.